Recent progress in biodiversity research on the Xylariales and their secondary metabolism.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
AbstractThe families Xylariaceae and Hypoxylaceae (Xylariales, Ascomycota) represent one of the most prolific lineages of secondary metabolite producers. Like many other fungal taxa, they exhibit their highest diversity in the tropics. The stromata as well as the mycelial cultures of these fungi (the latter of which are frequently being isolated as endophytes of seed plants) have given rise to the discovery of many unprecedented secondary metabolites. Some of those served as lead compounds for development of pharmaceuticals and agrochemicals. Recently, the endophytic Xylariales have also come in the focus of biological control, since some of their species show strong antagonistic effects against fungal and other pathogens. New compounds, including volatiles as well as nonvolatiles, are steadily being discovered from these ascomycetes, and polythetic taxonomy now allows for elucidation of the life cycle of the endophytes for the first time. Moreover, recently high-quality genome sequences of some strains have become available, which facilitates phylogenomic studies as well as the elucidation of the biosynthetic gene clusters (BGC) as a starting point for synthetic biotechnology approaches. In this review, we summarize recent findings, focusing on the publications of the past 3 years.
CitationJ Antibiot (Tokyo). 2020 Oct 23. doi: 10.1038/s41429-020-00376-0. Epub ahead of print.
AffiliationHZI,Helmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7,38124 Braunschweig, Germany.
JournalThe Journal of antibiotics
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 4.0 International
- Diversity of biologically active secondary metabolites from endophytic and saprotrophic fungi of the ascomycete order Xylariales.
- Authors: Helaly SE, Thongbai B, Stadler M
- Issue date: 2018 Sep 19
- Linking secondary metabolites to biosynthesis genes in the fungal endophyte Cyanodermella asteris: The anti-cancer bisanthraquinone skyrin.
- Authors: Jahn L, Schafhauser T, Wibberg D, Rückert C, Winkler A, Kulik A, Weber T, Flor L, van Pée KH, Kalinowski J, Ludwig-Müller J, Wohlleben W
- Issue date: 2017 Sep 10
- Biological and chemical diversity go hand in hand: Basidiomycota as source of new pharmaceuticals and agrochemicals.
- Authors: Sandargo B, Chepkirui C, Cheng T, Chaverra-Muñoz L, Thongbai B, Stadler M, Hüttel S
- Issue date: 2019 Nov 1
- Biologically Active Secondary Metabolites from the Fungi.
- Authors: Bills GF, Gloer JB
- Issue date: 2016 Nov
- Secondary metabolite biosynthetic diversity in the fungal family <i>Hypoxylaceae</i> and <i>Xylaria hypoxylon</i>.
- Authors: Kuhnert E, Navarro-Muñoz JC, Becker K, Stadler M, Collemare J, Cox RJ
- Issue date: 2021 Jun